Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of chiral sulfinamide phosphine compounds. Cost-effective route for high-purity pharmaceutical intermediates and fine chemicals.
Novel synthetic route for chiral ligands offering high enantioselectivity and simplified manufacturing for pharmaceutical intermediates and fine chemicals.
Discover high-efficiency NNN ligand metal complexes for 1,1-disubstituted alkene hydroboration. Cost-effective iron catalysis for pharmaceutical intermediates.
Patent CN110283036B details a novel column chromatography method for separating chiral diene ligands with 100% ee, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN117088828A details asymmetric catalysis for chiral fluorene. Enhances OLED material stability and offers cost reduction in electronic chemical manufacturing.
Patent CN109970713B details novel amino acid-based Ir(III) catalysts enabling high-efficiency asymmetric C-H activation for cost-effective API manufacturing.
Patent CN1321114C details an 8-step chemical synthesis for Orlistat, offering significant cost reduction and scalability compared to fermentation for pharmaceutical intermediate manufacturing.
Patent CN114105972A reveals a breakthrough cinchonine derivative catalyst achieving over 90% ee for indoxacarb intermediates, offering significant cost and supply chain advantages.
Patent CN103288876B details a novel chiral phosphamide synthesis. Discover cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN113444125A reveals high-ee ligand for alkaloid synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Discover high-purity axial chiral 4-aryl alpha-carboline intermediates synthesized via novel NHC organocatalysis. Reliable supply chain solutions for pharmaceutical manufacturing.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN101456838B details a metal-free chiral phosphoric acid catalyzed route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed route for tranylcypromine intermediates offers high ee values and cost-effective scaling for global pharmaceutical supply chains.
Patent CN1056612C details novel Salen-Mn catalysts and isoquinoline N-oxide ligands for enantioselective epoxidation, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel 3-step route for Pregabalin avoids resolution waste. High ee value up to 99.6%. Cost-effective manufacturing for pharma intermediates.
Patent CN117343075A reveals a novel organocatalytic route for high-purity chiral spirocyclic intermediates, offering significant supply chain stability and cost advantages.
Patent CN101392225A reveals a recombinant yeast route for high-purity (S)-CHBE, offering significant cost reduction in API manufacturing and robust supply chain scalability.
Patent CN102295582A reveals a novel rhodium-catalyzed three-component reaction for high-purity alpha-quaternary carbon diamino acids, offering significant cost reduction in API manufacturing.